Sotorasib (Lumakras) 120 mg Price in India – Access Affordable Treatment

Sotorasib (Lumakras) - Introduction

Sotorasib, marketed under the brand name Lumakras, is a groundbreaking therapy for patients with KRAS G12C-mutated non-small cell lung cancer (NSCLC). With its global approval from the US FDA and conditional approval by the European Medicines Agency (EMA), many patients in India are seeking information about sotorasib price in India and how to safely access the medicine. Since Lumakras is not approved for commercial sale in India, patients must explore special pathways, such as the Lumakras Named Patient Program India, or work with licensed access providers to legally and safely import the drug.

This guide explains how to import Lumakras to India, factors affecting treatment cost, dosing information for Lumakras 120 mg, and practical steps to ensure authenticity, all while helping patients and caregivers make informed decisions.

Why Access and Cost Matter in India

Accessing Lumakras 120 mg in India is challenging because the therapy is not locally approved, and it must be imported through regulated channels. Patients searching online for Sotorasib (lumakras) price in India often encounter inconsistent information, which can be confusing or misleading. The cost of treatment is influenced by multiple factors, including international currency exchange rates, import duties, and logistical charges, which makes it impossible to provide a fixed price.

Understanding how to access Lumakras safely and what affects its cost is crucial. Reliable information ensures patients can navigate the Lumakras Named Patient Program India efficiently and avoid potential risks associated with unverified suppliers.

How to Access Lumakras in India

Patients in India can access Lumakras primarily through the Named Patient Import Program (NPP), which allows physicians to request unapproved medicines for individual patients. To participate in this program, a patient must have a prescription from a treating oncologist, along with detailed medical records that justify the use of Sotorasib. The application is submitted to a licensed importer who coordinates with overseas suppliers to legally bring Lumakras into India.

Some advanced hospitals in India also provide support by directly liaising with international suppliers on a case-by-case basis. This ensures that patients receive genuine medication under professional supervision.

Licensed pharmaceutical access companies offer additional guidance. These providers assist patients in buying Sotorasib in India, managing documentation, handling import logistics, and ensuring regulatory compliance. For clear, step-by-step guidance, patients are encouraged to visit 24/7QualityMeds, which specializes in helping patients understand how to import Lumakras to India safely and efficiently.

Factors Affecting the Cost of Lumakras in India

While many patients search for lumakras price in India, it is important to note that the cost can vary due to several factors. The exchange rate between the US dollar or Euro and the Indian rupee directly impacts the price. Import duties, customs charges, and shipping fees also contribute to variability. Additionally, the fees charged by licensed importers, as well as the number of tablets required for a patient’s treatment plan, influence the total cost.

Because of these variables, the final cost of Sotorasib in India can differ for each patient. Patients seeking accurate and current pricing should always contact experienced suppliers such as 24/7 QualityMeds. They provide up-to-date guidance on costs, the import process, and regulatory compliance.

Dosing and Pack Information for Lumakras 120 mg

Lumakras is available in 120 mg film-coated tablets. The typical adult dose is 960 mg once daily, equivalent to eight tablets per day. The total number of tablets required is determined by the treating oncologist based on individual treatment plans. Understanding the required quantity helps patients plan for imports through the Lumakras Named Patient Program India, ensuring they receive the correct supply safely.

Regulatory Approvals and Safety

Globally, Lumakras has been approved to treat KRAS G12C-positive NSCLC patients who have previously received systemic therapy. The US FDA approval in 2021 and conditional approval from the EMA underline its clinical significance.

In India, however, Lumakras is not approved for commercial use, so all imports must comply with regulatory standards. Common side effects reported in clinical trials include diarrhea, nausea, fatigue, and liver enzyme elevations. Therefore, treatment should always be administered under the supervision of an oncologist to monitor safety and effectiveness.

Verifying Supplier Authenticity

Patients seeking to buy Sotorasib in India must verify that the supplier is licensed and provides official invoices, import permits, and batch information. Working with trusted pharmaceutical access companies ensures the medicine is authentic and delivered safely. Patients should always consult their treating oncologist before finalizing any import arrangements to guarantee the treatment is medically appropriate and compliant with Indian regulations.

Conclusion

Sotorasib (Lumakras) is a significant advancement for treating KRAS G12C-positive NSCLC, offering a targeted therapy option for patients with limited alternatives. Since it is not approved for commercial use in India, patients must rely on the Lumakras Named Patient Program India or licensed access providers to safely import the medicine.

Because costs are influenced by currency exchange rates, import duties, and logistics, patients are encouraged to consult with experienced suppliers. For detailed guidance on how to import Lumakras to India, step-by-step assistance, and regulatory compliance, patients should Contact 24/7 QualityMeds.

Frequently Asked Questions

Q. Is Lumakras available in India?
A: No, Lumakras is not commercially available. Patients can access it only through the Named Patient Import Program India or licensed access providers.

Q: How can I buy Sotorasib in India?
A: Patients can work with licensed importers and access companies to legally obtain Lumakras. Consultation with a treating oncologist is mandatory.

Q: Why does Lumakras price vary in India?
A: Costs fluctuate due to exchange rates, import duties, logistics, and pack sizes. Always contact a trusted supplier for accurate guidance.

Q: What is the Lumakras Named Patient Program India?
A: It is a legal mechanism for importing unapproved medicines for individual patients under physician supervision.

Q: How do I import Lumakras to India safely?
A: Work with licensed access providers, verify all documentation, and coordinate with your oncologist.

Q: Who can provide accurate cost and access guidance?
A: For reliable support, patients should visit 24/7 QualityMeds, which specializes in safe Lumakras import and guidance.